123 related articles for article (PubMed ID: 35373558)
41. X-ray structure of chromium(III)-containing transferrin: First structure of a physiological Cr(III)-binding protein.
Petersen CM; Edwards KC; Gilbert NC; Vincent JB; Thompson MK
J Inorg Biochem; 2020 Sep; 210():111101. PubMed ID: 32650146
[TBL] [Abstract][Full Text] [Related]
42. Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins.
Peterson NA; Anderson BF; Jameson GB; Tweedie JW; Baker EN
Biochemistry; 2000 Jun; 39(22):6625-33. PubMed ID: 10828980
[TBL] [Abstract][Full Text] [Related]
43. Spectroscopic and thermodynamic studies on the binding of gadolinium(III) to human serum transferrin.
Zak O; Aisen P
Biochemistry; 1988 Feb; 27(3):1075-80. PubMed ID: 2835077
[TBL] [Abstract][Full Text] [Related]
44. Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferrin.
Jeffrey PD; Bewley MC; MacGillivray RT; Mason AB; Woodworth RC; Baker EN
Biochemistry; 1998 Oct; 37(40):13978-86. PubMed ID: 9760232
[TBL] [Abstract][Full Text] [Related]
45. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.
Nagaoka MH; Akiyama H; Maitani T
Analyst; 2004 Jan; 129(1):51-4. PubMed ID: 14737583
[TBL] [Abstract][Full Text] [Related]
46. Two high-resolution crystal structures of the recombinant N-lobe of human transferrin reveal a structural change implicated in iron release.
MacGillivray RT; Moore SA; Chen J; Anderson BF; Baker H; Luo Y; Bewley M; Smith CA; Murphy ME; Wang Y; Mason AB; Woodworth RC; Brayer GD; Baker EN
Biochemistry; 1998 Jun; 37(22):7919-28. PubMed ID: 9609685
[TBL] [Abstract][Full Text] [Related]
47. Binding of the anticancer Ti(IV) complex phenolaTi to serum proteins: Thermodynamic and kinetic aspects.
Shpilt Z; Tshuva EY
J Inorg Biochem; 2022 Jul; 232():111817. PubMed ID: 35421765
[TBL] [Abstract][Full Text] [Related]
48. Regulation mechanisms of ferric ions release from iron-loaded transferrin protein caused by nano-sized polystyrene plastics-induced conformational and structural changes.
He F; Shi H; Hu S; Liu R
J Hazard Mater; 2024 Mar; 465():133495. PubMed ID: 38232549
[TBL] [Abstract][Full Text] [Related]
49. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Guo Z; Sadler PJ
J Biol Inorg Chem; 2001 Sep; 6(7):698-707. PubMed ID: 11681703
[TBL] [Abstract][Full Text] [Related]
50. Intact human holo-transferrin interaction with oxaliplatin.
Zhao YY; Mandal R; Li XF
Rapid Commun Mass Spectrom; 2005; 19(14):1956-62. PubMed ID: 15954173
[TBL] [Abstract][Full Text] [Related]
51. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.
Lebrón JA; West AP; Bjorkman PJ
J Mol Biol; 1999 Nov; 294(1):239-45. PubMed ID: 10556042
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous multiple element detection by particle beam/hollow cathode-optical emission spectroscopy as a tool for metallomic studies: determinations of metal binding with apo-transferrin.
Quarles CD; Brumaghim JL; Marcus RK
Metallomics; 2010 Feb; 2(2):154-61. PubMed ID: 21069147
[TBL] [Abstract][Full Text] [Related]
53. Exploring the Fe(III) binding sites of human serum transferrin with EPR at 275 GHz.
Mathies G; Gast P; Chasteen ND; Luck AN; Mason AB; Groenen EJ
J Biol Inorg Chem; 2015 Apr; 20(3):487-96. PubMed ID: 25537134
[TBL] [Abstract][Full Text] [Related]
54. Dynamics of Human Serum Transferrin in Varying Physicochemical Conditions Explored by Using Molecular Dynamics Simulations.
Indrakumar S; Kulakova A; Harris P; Peters GHJ
Mol Pharm; 2022 Aug; 19(8):2795-2806. PubMed ID: 35776490
[TBL] [Abstract][Full Text] [Related]
55. Composition of pH-sensitive triad in C-lobe of human serum transferrin. Comparison to sequences of ovotransferrin and lactoferrin provides insight into functional differences in iron release.
Halbrooks PJ; Giannetti AM; Klein JS; Björkman PJ; Larouche JR; Smith VC; MacGillivray RT; Everse SJ; Mason AB
Biochemistry; 2005 Nov; 44(47):15451-60. PubMed ID: 16300393
[TBL] [Abstract][Full Text] [Related]
56. Structural and functional consequences of binding site mutations in transferrin: crystal structures of the Asp63Glu and Arg124Ala mutants of the N-lobe of human transferrin.
Baker HM; He QY; Briggs SK; Mason AB; Baker EN
Biochemistry; 2003 Jun; 42(23):7084-9. PubMed ID: 12795604
[TBL] [Abstract][Full Text] [Related]
57. Iron and gallium increase iron uptake from transferrin by human melanoma cells: further examination of the ferric ammonium citrate-activated iron uptake process.
Richardson DR
Biochim Biophys Acta; 2001 Apr; 1536(1):43-54. PubMed ID: 11335103
[TBL] [Abstract][Full Text] [Related]
58. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS.
Nagaoka MH; Yamazaki T; Maitani T
Biochem Biophys Res Commun; 2002 Sep; 296(5):1207-14. PubMed ID: 12207902
[TBL] [Abstract][Full Text] [Related]
59. Direct thermodynamic and kinetic measurements of Fe²⁺ and Zn²⁺ binding to human serum transferrin.
Terpstra T; McNally J; Han TH; Ha-Duong NT; El-Hage-Chahine JM; Bou-Abdallah F
J Inorg Biochem; 2014 Jul; 136():24-32. PubMed ID: 24705244
[TBL] [Abstract][Full Text] [Related]
60. Interaction Between the Transferrin Protein and Plutonium (and Thorium), What's New?
Zurita C; Tsushima S; Solari PL; Menut D; Dourdain S; Jeanson A; Creff G; Den Auwer C
Chemistry; 2023 Oct; 29(55):e202300636. PubMed ID: 37526142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
